Cara Therapeutics, Inc. (CARA) SEC filings
CARA SEC filings moved a median of -1.61% by the close. CARA SEC filings — 10-K, 10-Q, 8-K and the rest — each read against the price at its own news timestamp. Back to the CARA overview →
39 measured CARA SEC filing events.
Where these CARA SEC filings landedvs 35 measured CARA SEC filing reactions
| Middle 50% of CARA SEC filing reactions | -4.98% to +1.95% |
|---|---|
| Median reaction (to close) | -1.61% |
| Measured reactions | 35 |
Point-in-time · zero look-ahead
Half of the 35 CARA SEC filing events with a measured close landed between -4.98% and +1.95%; 34% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q Tvardi Therapeutics, For: Mar 31 | SEC filing · Form 10-Q | — | — | |
| Form 8-K Tvardi Therapeutics, For: May 12 | SEC filing · Form 8-K | — | — | |
| Form 8-K/A Tvardi Therapeutics, For: Apr 15 | SEC filing · Form 8-K | — | — | |
| Form 8-K Tvardi Therapeutics, For: Apr 15 | SEC filing · Form 8-K | — | — | |
| Form 8-K Cara Therapeutics, Inc. For: Apr 11 | SEC filing · Form 8-K | +0.20% | +11.00% | |
| Form 8-K Cara Therapeutics, Inc. For: Apr 01 | SEC filing · Form 8-K | +0.00% | +2.00% | |
| Form 8-K Cara Therapeutics, Inc. For: Mar 24 | SEC filing · Form 8-K | +0.00% | -1.19% | |
| Form 10-K Cara Therapeutics, Inc. For: Dec 31 | SEC filing · Form 10-K | +0.00% | -1.73% | |
| Form EFFECT Cara Therapeutics, Inc. | SEC filing · Form EFFECT | +0.00% | -4.00% | |
| Form S-4/A Cara Therapeutics, Inc. | SEC filing · Form S-4 | -3.53% | -6.98% | |
| Form S-4/A Cara Therapeutics, Inc. | SEC filing · Form S-4 | -3.84% | -9.68% | |
| Form 8-K Cara Therapeutics, Inc. For: Jan 16 | SEC filing · Form 8-K | -1.72% | -0.86% | |
| Form 8-K Cara Therapeutics, Inc. For: Jan 14 | SEC filing · Form 8-K | -1.72% | -0.86% | |
| Form 8-K Cara Therapeutics, Inc. For: Dec 30 | SEC filing · Form 8-K | +1.91% | +46.41% | |
| Form 8-K/A Cara Therapeutics, Inc. For: Dec 17 | SEC filing · Form 8-K | +3.31% | +7.40% | |
| Form 8-K Cara Therapeutics, Inc. For: Dec 17 | SEC filing · Form 8-K | -7.96% | +4.84% | |
| Form S-4 Cara Therapeutics, Inc. | SEC filing · Form S-4 | -2.16% | +57.82% | |
| Form 8-K Cara Therapeutics, Inc. For: Nov 19 | SEC filing · Form 8-K | +0.40% | +0.23% | |
| Form 10-Q Cara Therapeutics, Inc. For: Sep 30 | SEC filing · Form 10-Q | +0.41% | -2.87% | |
| Form 10-Q Cara Therapeutics, Inc. For: Jun 30 | SEC filing · Form 10-Q | +0.00% | -1.81% | |
| Form 8-K Cara Therapeutics, Inc. For: Jul 31 | SEC filing · Form 8-K | -1.22% | +0.41% | |
| Form 8-K Cara Therapeutics, Inc. For: Jun 14 | SEC filing · Form 8-K | -5.88% | -5.15% | |
| Form 8-K Cara Therapeutics, Inc. For: Jun 12 | SEC filing · Form 8-K | -11.37% | -10.60% | |
| Form 8-K Cara Therapeutics, Inc. For: Jun 04 | SEC filing · Form 8-K | +3.65% | +7.36% | |
| Form 10-Q Cara Therapeutics, Inc. For: Mar 31 | SEC filing · Form 10-Q | -4.14% | -4.98% | |
| Form 8-K Cara Therapeutics, Inc. For: May 13 | SEC filing · Form 8-K | -4.14% | -4.98% | |
| Form ARS Cara Therapeutics, Inc. For: Dec 31 | SEC filing · Form ARS | -1.92% | -1.61% | |
| Form DEF 14A Cara Therapeutics, Inc. For: Jun 04 | SEC filing · Form DEF | -1.92% | -1.61% | |
| Form DEFA14A Cara Therapeutics, Inc. | SEC filing · Form DEFA14A | -1.92% | -1.61% | |
| Form PRE 14A Cara Therapeutics, Inc. For: Jun 04 | SEC filing · Form PRE | +1.96% | -7.19% | |
| Form 8-K Cara Therapeutics, Inc. For: Mar 19 | SEC filing · Form 8-K | +5.63% | -4.31% | |
| Form S-8 Cara Therapeutics, Inc. | SEC filing · Form S-8 | -0.97% | +3.96% | |
| Form 8-K Cara Therapeutics, Inc. For: Mar 04 | SEC filing · Form 8-K | -0.92% | +1.93% | |
| Form 8-K Cara Therapeutics, Inc. For: Feb 01 | SEC filing · Form 8-K | +0.00% | +1.97% | |
| Form 8-K Cara Therapeutics, Inc. For: Jan 17 | SEC filing · Form 8-K | -3.14% | -1.18% | |
| Form 8-K Cara Therapeutics, Inc. For: Dec 18 | SEC filing · Form 8-K | -18.50% | -46.23% | |
| Form 10-Q Cara Therapeutics, Inc. For: Sep 30 | SEC filing · Form 10-Q | -11.11% | -6.41% | |
| Form 8-K Cara Therapeutics, Inc. For: Nov 13 | SEC filing · Form 8-K | -11.11% | -6.41% | |
| Form 8-K Cara Therapeutics, Inc. For: Nov 01 | SEC filing · Form 8-K | +4.92% | -2.46% |
Keep exploring
More CARA: earnings → · analyst actions → · CARA overview →
Other Healthcare names and their SEC filings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Patterson Companies, Inc. (PDCO) | 144 | 0.00% | 48% |
| Propanc Biopharma, Inc. (PPCB) | 144 | 0.00% | 41% |
| Nutriband Inc. (NTRB) | 143 | 0.00% | 44% |
| Redhill Biopharma Ltd. - American Depositary Shares (RDHL) | 143 | -0.50% | 39% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its SEC filings — that is what the link opens.